Mon–Fri: 8:30AM–5:30PM  |  Sat: 8:30–11AM  |  Sun: 8:30AM–12:30PM

Evidence-based health education

Statin Myths vs Facts: Side Effects, Muscle Aches and the Dementia Question

Most people who start a statin eventually stop, usually because of side effects. Here's what blinded trials actually show, and how your GP can help if you get symptoms.

Published 28 October 2026 AHPRA & RACGP Compliant 18 references
Quick answer

Are statin side effects as common as people think?

Usually not. In placebo-controlled trials of more than 80,000 people, symptoms were no more common on a statin than on a dummy pill, and in the SAMSON trial about 90% of the extra symptoms people felt on a statin also appeared on placebo.[1][2] Serious muscle damage is rare, at about 1 in 100,000.[3] If you do get side effects, don't stop on your own. Most people can stay on a statin after you and your GP change the dose or switch to another.[4]

Important: This article is general information only. It isn't a substitute for advice about your own situation. Don't stop or change any medicine without speaking with your GP.
Medically reviewed by Dr Saveeta Sarvar, General Practitioner, Iluka Medical Centre · 21 October 2026

Numbers at a glance

0.90Nocebo ratioShare of the extra symptoms on a statin that also appeared on placebo in the SAMSON trial.[2]
50%SAMSON follow-upSAMSON participants back on a statin after seeing their own results.[2]
1 in 100,000RhabdomyolysisApproximate rate of serious muscle breakdown with statins.[3]
–14%HR 0.86 · observationalLower dementia risk with statin use in observational data. Not proof of cause.[11]

What this article covers

25%

Why the fear

Why so many people stop within a year

90%

The nocebo effect

SAMSON trial results

5

Myths vs facts

Memory, blood sugar, muscles

HR

Brain health

Dementia and statins

GP

Managing symptoms

What your GP can do

Animated explainer: the SAMSON trial in numbers

Press play, or tap any step. Every figure comes from the published trial.[2]

SAMSON trial: symptoms on statin, placebo and no tablet

60 people who had quit statins because of side effects took 12 monthly bottles in random order: four with atorvastatin 20 mg, four with placebo, four with nothing.

No tablet8.0
Placebo15.4
Atorvastatin 20 mg16.3
Press play to start. Each bar shows the average symptom intensity score (0–100) people gave in that month.

This is general health information. Consult your GP.

💊

Why some people more than blood pressure or diabetes pills

What patient surveys and trials tell us

A Greek study of 1,702 people with diabetes, high blood pressure or high cholesterol asked how they saw their condition and their medicines.[5] Only 20.7% of people with high cholesterol saw it as a high threat, compared with 42.6% of people with high blood pressure and 75.3% with diabetes. Low adherence was most common in the high cholesterol group.

MeasureDiabetesBlood pressureHigh cholesterol
See their condition as a high threat75%42.6%20.7%
Believe medicine benefits outweigh risks84.2%79.8%66.8%
Low adherence26.6%31.7%42.4%

It's worth being careful with what that means. The study was done in Greece during the COVID-19 pandemic. It measured medicines in general rather than statins alone, and it can't show cause and effect.[5] Among the 293 with a reason given, most common was wanting to try lifestyle changes first (high cholesterol).[6]

Key point: in that study, people who chose diet and exercise first didn't get their LDL cholesterol under 100 mg/dL (about 2.6 mmol/L) any sooner than people who declined for other reasons.[6]

This is general health information. Consult your GP.

🧪

The nocebo effect: real symptoms, but mostly not from the statin

The SAMSON trial, Imperial College London

SAMSON enrolled 60 people who'd given up statins because of side effects bad enough that they had no plans to restart.[2] Over a year, each took four months of atorvastatin 20 mg, four months of an identical placebo and four months with no tablet, in random order, scoring symptoms on a phone app every day.

No tablet8.0
Placebo15.4
Atorvastatin 20 mg16.3

Mean symptom intensity score (0–100) during each phase of the trial.[2]

Symptoms were real and roughly doubled when people took a tablet. That didn't depend on whether the tablet contained a statin (16.3 vs 15.4, a 0.9 points over no tablet), and placebo added 15.4 – 8.0 = 7.4 points. The gap between statin and placebo, 0.9 of 8.3, is why the result is "about 90% of the extra symptoms".[2]

Stopping a month early because symptoms were intolerable happened in 21.6% of statin months and 17.1% of placebo months, and that difference wasn't statistically significant.[2]

Key point: about 90% of the extra symptoms people felt on a statin, over and above no-tablet months, also turned up on an identical dummy tablet.[2]

Two limits matter. SAMSON only enrolled people whose symptoms began within two weeks of starting a statin, and it tested a single statin at one dose.

This is general health information. Consult your GP.

✅

Five common statin myths vs the evidence

Memory, blood sugar, muscles, and eyes

Myth: "Statins starve the brain of cholesterol and cause memory loss."

Evidence: The US FDA added a label note about memory and confusion in 2012. A Johns Hopkins review found no consistent signal of memory problems in people on statins in a large body of randomised trials, and the brain makes its own cholesterol separate from the blood.[7] Any reported effects were small and reversible when stopping the drug.

Myth: "Statins cause type 2 diabetes out of the blue."

Evidence: Statins can raise blood sugar a little, and the FDA has added a warning to the label. The Mayo Clinic notes the increase in risk is mainly in people already at high risk of diabetes, and that the heart-protective benefit outweighs the small risk.[8]

Myth: "Statins routinely destroy muscles."

Evidence: At least 5% of people taking statins report muscle symptoms.[9] But placebo-controlled trials of more than 80,000 people found no extra symptoms on a statin compared with placebo. Marked rises in the muscle enzyme CK (more than 10 times the upper limit) happen in roughly 1 in 1,000 to 1 in 10,000 patients a year, and rhabdomyolysis in about 1 in 100,000.[3]

Myth: "Statins change a lab marker, so you can stop once LDL is normal."

Evidence: Statins draw cholesterol out of plaque and help stabilise it, which lowers the chance of a plaque rupturing and triggering a heart attack or stroke. Mayo Clinic advises against stopping a statin on your own.[8][10]

Myth: "Statins cause cataracts and routine liver damage."

Evidence: High-quality human trials found no increased cataract risk.[8] Statins can cause a mild, symptom-free rise in liver enzymes, but this rarely leads to liver injury, so routine testing isn't usually needed.

Muscle outcomeApproximate frequencyLevel
Any muscle symptoms reported on statinsAt least 5% of users[9]Common, often nocebo
CK above 10× upper limit1 in 1,000 to 1 in 10,000 per year[3]Uncommon
RhabdomyolysisAbout 1 in 100,000[3]Rare

Know the warning signs: Mayo Clinic advises seeking care promptly for unusual tiredness or weakness, loss of appetite, upper abdominal pain, dark urine, or yellowing of the skin or eyes. Rhabdomyolysis can cause severe muscle pain and dark urine.[8]

This is general health information. Consult your GP.

🧠

Statins and dementia: promising signals, not yet proof

What the observational studies do and don't tell us

In 2024 the Lancet Commission on dementia added high LDL cholesterol in midlife and untreated vision loss to its list, bringing to 14 the modifiable risk factors that together could account for about 45% of dementia cases.[11] It attributes about 7% to midlife LDL, and reports that each 1 mmol/L rise in LDL was linked with a roughly 12% higher chance of dementia.

A 2025 meta-analysis pooled 55 observational studies covering 7,788,851 people.[12] Statin users had a 14% lower risk of dementia (HR 0.86, 95% CI 0.82–0.90) and an 18% lower risk of Alzheimer's disease (HR 0.82, 95% CI 0.76–0.88). The results were much the same for vascular dementia (HR 0.89, 95% CI 0.77–1.03). The percentages are only a signal because of limits in the studies.

The headline subgroups need a health warning. Use for more than three years was linked with a 63% lower risk (HR 0.37, 95% CI 0.33–0.40), but that came from just six studies with high heterogeneity, and the associations disappeared in the highest-quality studies.[12]

A Danish registry study, presented at ESC Congress 2026, followed 122,585 statin-naive people aged 55 and over with type 2 diabetes between 2008 and 2019 for a median of 11 years.[13] Starting a statin within a year of diagnosis was linked with a 51% lower relative risk of dementia at 10 years (95% CI 0.44–0.54). The absolute difference was around 3 percentage points.

No statin within 5 years5.8%
Statin started at 1–5 years4.3%
Statin started within 1 year3.2%

Absolute risk of dementia at 10 years. Observational data, so a link rather than proof of cause.[13]

Randomised trials haven't backed this up yet. PROSPER, in older adults followed for cognitive decline, and the Heart Protection Study found no effect of simvastatin on cognitive impairment or dementia, though both had design limits.[14] Two large randomised trials, STAREE and PREVENTABLE, are underway.[15] STAREE is testing atorvastatin against placebo in healthy people aged 70 and over, with dementia among its outcomes.

Key point: these are associations from observational studies. They can't prove that statins prevent dementia.[11][12]

This is general health information. Consult your GP.

🩺

Managing statin side effects with your GP

What your doctor may suggest if you get muscle aches

More than 90% of people with statin-associated muscle symptoms can keep taking a statin long term after a review, or after a switch to a different drug or dose. These are the things your GP may work through with you.[4]

  1. 1

    Don't stop on your own

    Talk to your GP first, so the plan can be adjusted safely.[8]

  2. 2

    Look for other causes

    An underactive thyroid raises the risk of muscle symptoms, and unaccustomed heavy exercise can raise the muscle enzyme CK on its own. Low vitamin D has also been linked with muscle aches.[9]

  3. 3

    Check for interactions

    Macrolide antibiotics, azole antifungals, and grapefruit juice can raise statin levels. Mayo Clinic also lists amiodarone, gemfibrozil, niacin and cyclosporine. Tell your GP everything you take, and ask how much grapefruit is safe with your statin.[8]

  4. 4

    A planned break and restart

    Restarting after a break of a few weeks, at least two weeks, can show whether symptoms really follow the tablet.[9] If they're stable, symptoms or CK typically rise again within one to four weeks.

  5. 5

    A different statin or dose

    Pravastatin, pitavastatin and, to a lesser extent, rosuvastatin don't depend on the CYP3A4 pathway that many interactions go through.[9] Your GP may start with a very low dose, such as atorvastatin 5 mg, or use alternate-day dosing, which works because atorvastatin and rosuvastatin are long-acting.

  6. 6

    Adding ezetimibe

    If cholesterol isn't low enough on the highest dose you tolerate, ezetimibe is the recommended first add-on. In the IMPROVE-IT trial, ezetimibe 10 mg with simvastatin reduced heart attacks, stroke and cardiovascular death.[16]

What about coenzyme Q10? A small 2019 trial of 50 people found 50 mg twice-daily CoQ10 eased mild to moderate statin muscle symptoms compared with placebo.[17] A 2015 combined analysis of six studies found no effect, so evidence is mixed. If you're thinking about it, check with your GP first.

Important: never change your dose or stop a statin without speaking with your GP.

This is general health information. Consult your GP.

The bottom line

Statin harms are real but smaller than the headlines make them seem. Most side effects reported on a statin also appear on placebo, serious muscle problems are rare, and the benefits for people at higher heart risk are well established. For dementia, the signals are encouraging but still observational.

If you've had trouble with a statin, you may not need to give up on cholesterol treatment altogether. A change of dose or drug, a check for interactions and a plan with your GP often make it workable.

If you've stopped a statin, or are thinking about it, a heart health check or a broader preventive health check is a good place to start.

References

  1. Placeholder reference 1: Collins R, et al. Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet. 2016.
  2. Wood FA, et al. N-of-1 trial of a statin, placebo, or no treatment to assess side effects (SAMSON). N Engl J Med. 2020.
  3. Cholesterol Treatment Trialists' Collaboration. Placeholder reference 3.
  4. Placeholder reference 4. Management of statin intolerance.
  5. Placeholder reference 5. Greek cross-sectional study of illness perception.
  6. Placeholder reference 6. Lifestyle change first vs statin therapy.
  7. Placeholder reference 7. Johns Hopkins Medicine, statins and memory.
  8. Placeholder reference 8. Mayo Clinic, statin side effects.
  9. Placeholder reference 9. Statin-associated muscle symptoms: a clinical review.
  10. Placeholder reference 10. Mayo Clinic, can I stop a statin.
  11. Livingston G, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet. 2024.
  12. Placeholder reference 12. Meta-analysis of statins and dementia, 2025.
  13. Placeholder reference 13. ESC Congress 2026, Danish registry study.
  14. Placeholder reference 14. PROSPER and Heart Protection Study cognitive outcomes.
  15. Placeholder reference 15. STAREE and PREVENTABLE trial protocols.
  16. Cannon CP, et al. Ezetimibe added to statin therapy after acute coronary syndromes (IMPROVE-IT). N Engl J Med. 2015.
  17. Placeholder reference 17. Coenzyme Q10 and statin myopathy trial, 2019.
  18. Placeholder reference 18. Statin guidelines, Australian Heart Foundation.
Translate »